MHC Class I Presented T Cell Epitopes as Potential Antigens for Therapeutic Vaccine against HBV Chronic Infection
Table 1
HBV specific MHC class I restricted peptides identified by immunoproteomics. The LC-MS/MS selection criteria for peptides are as follows: Charge 1: Xcorr > 1.6; Charge 2: Xcorr > 1.8; Charge 3: Xcorr > 2.0. The HLA binding scores were calculated using the SYFPEITHI prediction program [28].
